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Summary 
 
 Intercellular adhesion molecules play an important role in the generation of 
T lymphocyte-mediated immune responses.  Here, we describe a novel 
accessory molecule, DNAX accessory molecule-1 (DNAM-1), that is constitutively 
expressed on the majority of peripheral blood T lymphocytes.  DNAM-1 is a 65 
KD transmembrane glycoprotein consisting of 318 amino acids including two 
immunoglobulin-like domains.  Anti-DNAM-1 monoclonal antibody (mAb) inhibits 
T and NK cell-mediated cytotoxicity against a variety of tumor cell targets and 
blocks cytokine production by alloantigen-specific T cells.  In addition, DNAM-1 
is a tyrosine-phosphorylated signal transducing molecule that participates in 
primary adhesion during cytotoxic T lymphocytes (CTL)-mediated cytotoxicity.  
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Introduction 
 T lymphocyte-mediated cytotoxicity is a complex process involving engagement 
of the CD3/T cell antigen receptor complex (TcR), signal transduction, and subsequent 
cytolysis of target cells (Apasov, et al., 1993; Berke, 1994, 1995;  Henkart, 1994).  In 
addition to specific antigen recognition by the TcR, CTL require the engagement of 
intercellular accessory molecules on T cells by their respective ligands expressed on 
target cells (Springer, 1990; Phillips, et al., 1991; O'Rourke and Mescher, 1992; 
Rodrigues, et al., 1992).  A variety of accessory molecules expressed on T cells 
(including CD8, CD4, CD28, LFA-1 and CD2) are involved in this process (Bierer, et al., 
1989; Janeway, 1988; Kupfer and Singer, 1989; Springer et al. 1987; Dustin and 
Springer, 1989; Kishimoto, et al., 1987; Vives, 1994).  Accessory molecules facilitate 
the intercellular conjugation of CTL with target cells and transduce signals which 
augment or synergize with signals from the TcR (Bierer, et al., 1989; Springer, 1990).  
 The adhesion molecules LFA-1 and CD2 are crucial for cytotoxicity mediated by 
many CTL (Shaw, et al., 1986; Springer, 1990).  CTL-mediated cytotoxicity, however, 
is often not completely blocked in the presence of anti-CD2 or anti-LFA-1 mAb 
(unpublished observation), suggesting the existence of other adhesion molecule(s) on 
CTL that are involved in the cytolytic process.  In the present investigation, we have 
identified a novel signal transducing adhesion molecule, DNAM-1, that is involved in 
cytotoxicity and lymphokine secretion mediated by CTL.  Here, we describe the 
functional and molecular characteristics of DNAM-1. 
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Results  
 
DNAM-1 is involved in T cell and NK cell-mediated cytotoxicity 
  Many CTL clones mediate "promiscuous" or "natural killer (NK)-like" lysis 
against a variety of tumor cell targets by an unknown mechanism that is independent of 
TcR engagement (TcR-independent cytotoxicity).  To identify the accessory molecules 
involved in this process, we generated mAbs against a human CTL clone that inhibited 
TcR-independent  cytotoxicity.  The mAb DX11 was selected because of its ability to 
block cytotoxicity against a variety of tumor cell lines (Fig. 1A).  The antigen recognized 
by the DX11 mAb was designated DNAX accessory molecule-1 (DNAM-1).  The DX11 
mAb inhibited lysis of both hematopoietic and non-hematopoietic target cells, but was 
selective in that anti-DNAM-1 did not affect killing of certain target cells (e.g. the JY and 
721.221 EBV-transformed B lymphoblastoid cell lines) (Fig. 1A).  Since DNAM-1 is 
expressed on the CTL but not on many of these tumor cell targets, these results 
indicated that DNAM-1 inhibits cytotoxicity at the level of the effector cell.  Similar 
results were obtained when CTL were precoated with DX11 mAb and washed prior to 
the addition of the target cell lines (not shown).  DNAM-1 is also expressed on NK cell 
clones and F(ab')2 fragments of the DX11 mAb efficiently inhibited the NK cell-mediated 
cytotoxicity against these tumor cell targets, but did not affect cytotoxicity against JY or 
721.221 (Fig. 1B).  
 
DNAM-1 expression on hematopoietic cells 
 In peripheral blood, DNAM-1 is expressed on the majority of α/β-TcR+ T cells, 
γ/δ−TcR+ T cells, NK cells (CD3-,CD56+), monocytes (CD14+), and a subset of B cells 
(Fig. 2), but is not on granulocytes or erythrocytes (data not shown).  DNAM-1 is also 
expressed on a subset of thymocytes co-expressing high surface density CD3 and on a 
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variety of transformed hematopoietic cells (data not shown).  DNAM-1, however, is not 
present on fibroblastic cell lines nor was it detected on tumor cell lines of epithelial or 
neuronal derivation (including the Colo-205 colon carcinoma cell line, the PA-1 ovarian 
teratocarcinoma cell line, the SK-N-SH neuroblastoma cell line, the MCF-7 breast 
carcinoma cell line, the BDMEL-1 melanoma cell line, and the CaOV3 ovarian 
carcinoma cell line). 
 
DNAM-1 is involved in the antigen-specific cytotoxicity and lymphokine secretion 
mediated by CTL 
  HLA-A2-specific CD8+ CTL clones expressing cell surface DNAM-1 (Fig. 3A) 
lysed the HLA-A2-expressing tumor lines JY and Colo-205 and cytotoxicity was 
completely inhibited by anti-HLA-A2 or anti-CD3 mAbs.  Addition of the DX11 mAb to 
the cytotoxicity assays inhibited cytolysis of Colo-205, but had no effect on the cytolysis 
of JY (Fig. 3B).  Anti-CD18 mAb blocked alloantigen-specific lysis of both Colo-205 and 
JY, demonstrating that LFA-1 is involved in cytotoxicity against both targets whereas 
DNAM-1 is preferentially involved in killing of Colo-205 and not JY. 
  Experiments were undertaken to determine if DNAM-1 is also required for 
lymphokine secretion initiated by alloantigen recognition.  DX11 mAb, as well as anti-
CD18 or anti-HLA-A2 mAb, significantly inhibited the secretion of TNFα and IFN-γ by 
the CTL co-cultured with Colo-205 (Fig. 3C).  By contrast, the cytokine secretion by the 
CTL clones induced by JY was not inhibited by DX11 mAb.  
 
DNAM-1 is a signal transducing molecule. 
 mAb against CD2 and CD3 are able to trigger cytolytic activity when CTL are co-
cultured with target cells expressing Fc receptors (Spits, et al., 1985; Mentzer, et al, 
1985; Siliciano, et al., 1985; Scott, et al., 1989).   As demonstrated in Fig. 4A, the 
DX11 mAb is also capable of inducing antibody-mediated re-direct cytolysis when CTL 
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are co-cultured with the murine Fc receptor-bearing P815 mastocytoma.  The 
magnitude of the antibody-induced cytolysis was comparable to that observed with a 
mAb against CD3.  In addition to enhancing conjugate formation between the CTL and 
P815 targets, DNAM-1 also appears to actively participate in signaling.  As shown in 
Fig. 4B, engagement of DNAM-1 by DX11 mAb-coated P815 target cells resulted in 
tyrosine phosphorylation of DNAM-1, with maximum phosphorylation occurring about 1 
min after addition of the mAb.  
 
DNAM-1 protein purification and cDNA cloning 
 DNAM-1 protein was purified from lysates of peripheral blood mononuclear cells 
(PBMC) using lectin affinity and  DX11 mAb-affinity chromatography.  The amino acid 
sequences of the N-terminal and  three internal peptide fragments were obtained from 
the purified DNAM-1 protein (Fig. 5A).  Degenerate oligonucleotide primers were 
designed based on the N-terminal and an internal peptide residues and used to amplify 
a 100 base pair (bp) cDNA fragment from a T cell cDNA library.  The 100 bp fragment 
was then used as a probe to isolate a full length DNAM-1 cDNA (Fig. 5A).  The DNAM-
1 cDNA is 2,603 bp and contains an open reading frame encoding a type-I 
transmembrane protein with an 18 amino acid (aa) leader sequence, 230 aa 
extracellular domain, 28 aa transmembrane domain, and 60 aa cytoplasmic region.  
Two pairs of cysteine residues in the extracellular domain were flanked by consensus 
sequences for  immunoglobulin-like domains (Fig. 5B ), indicating that DNAM-1 is a 
member of the immunoglobulin supergene family.  Three tyrosines are present in the 
cytoplasmic domain, and the REDIYNYP sequence may be phosphorylated by a src 
kinase (on the Y just down from the EDI) and is a possible binding site for Grb2 (Cantley 
and Songyang, 1994). Southern blot analysis of human genomic DNA suggests that 
DNAM-1 is encoded by a single gene (not shown).  The DNAM-1 gene is located on 
chromosome 18q22.3, as determined by fluorescence in situ hybridization (Callen, et al., 
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1990).  DNAM-1 is unique, demonstrating no significant homology to other protein or 
nucleotide sequences in the GenBank, EMBL or PIR databases.  Although 
demonstrating only 22% homology, DNAM-1 is most similar to the tactile receptor 
(Wang, et al., 1992) that is also expressed on CTL. 
 The DNAM-1 cDNA was transfected into COS-7 cells, which resulted in surface 
expression of DNAM-1 protein as detected by immunofluorescence using the DX11 
mAb (Fig. 5C).  The molecular weight of DNAM-1 immunoprecipitated from 125I-
labeled lysates of both PBMC and COS-7 cells transfected with DNAM-1 cDNA was ~65 
KD when analyzed by SDS-PAGE under both reducing and non-reducing conditions 
(Fig. 5C).  The mobility of DNAM-1 decreased from ~65 KD to ~35 KD after treatment 
with N-glycosidase F (Fig. 5D), consistent with the size of the polypeptide predicted 
from the DNAM-1 cDNA and the presence of 8 potential N-linked glycosylation sites in 
the extracellular domain (Fig. 5A).   
 
DNAM-1 is an adhesion molecule. 
 The observation that DX11 mAb blocked CTL and NK lysis of some, but not all, 
targets suggested that certain cells may express cell surface ligands for DNAM-1.  
Therefore, experiments were performed to determine if cells with a putative DNAM-1 
ligand, such as Colo-205, would specifically adhere to COS-7 cells transfected with 
DNAM-1 cDNA.  As shown in Fig. 6,  Colo-205 cells displayed significant binding to 
DNAM-1+ COS-7 transfectants and this binding was specifically inhibited by the DX11 
mAb.  Visual examination of these cultures also indicated substantial clustering of 
Colo-205 cells to DNAM-1 transfected COS-7 cells, but not untransfected COS-7 cells 
(not shown). 
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Discussion  
 A successful strategy to identify membrane receptor on T lymphocytes involved 
in CTL function has been to generate monoclonal antibodies that block cytolysis.  
Using this approach, LFA-1 (CD11a/CD18), CD2, and CD8 have been implicated as 
accessory molecules participating in cytolytic function (reviewed in Bierer and Burakoff, 
1991; Berke, 1994).  However, it is possible to generate CTL from patients lacking 
LFA-1 expression (van de Wiel-van Kemenade, et al., 1992) and from mice with 
disrupted CD2 genes (Killeen, et al., 1992).  Also because mAb against LFA-1, CD2, 
and CD8 often only partially block cytotoxicity, it seemed likely that other receptors 
involved in CTL function exist, prompting us to search for such molecules.  DNAM-1 
was identified by selecting  a mAb that inhibit CTL and NK cell-mediated lysis.  Like 
CD2 and LFA-1, DNAM-1 is expressed on most T and NK cells and functions as an 
intercellular adhesion molecule involved in cytolytic activity and lymphokine secretion.  
Functional studies suggest that the ligand for DNAM-1 (DNAM-1L) is a cell surface 
antigen broadly expressed on both hematopoietic and non-hematopoietic tissues.  
Similarly, the ligands for LFA-1, i.e. CD54 (Marlin and Springer, 1987; Rothlein, et al., 
1986), and CD2, i.e. CD58 (Krensky, et al., 1983; Dustin, et al., 1987), are also 
expressed on many cell types, allowing NK and T cells to interact with endothelial cells 
and epithelial tissues during immune responses.  Further studies are underway to 
identify the DNAM-1L and determine the structural requirements involved in DNAM-1 
binding. 
 Because essentially all T and NK cells express LFA-1, CD2, and DNAM-1 the 
relative contribution of these receptors may depend upon the array and density of their 
ligands present on the antigen-presenting cells or target cells.  In some situations, 
blocking any single receptor-ligand interaction may only partially or fail to inhibit CTL 
function because other molecules are operational.  Under other circumstances the 
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combination of several receptors may be necessary to achieve the threshold of binding 
or signaling required to activate effector function, in which case blocking any one of 
several accessory molecules may be sufficient to completely inhibit cytotoxicity.  The 
function of some adhesion molecules is affected by signals transmitted by the TcR.  
Dustin and Springer have shown that the affinity of LFA-1 for its ligand is transiently 
enhanced after TcR binding. (Dustin and Springer, 1989).  Thus, the role of the various 
adhesion molecules in lymphocyte - APC interactions may be dictated by a dynamic 
process and influenced by signals generated through other membrane receptors. 
 Intercellular adhesion molecules provide not only for cell binding, but also 
participate in signal transduction.  mAbs against CD2 function as agonists and can 
trigger CTL and NK cell cytolytic function (Siliciano, et al., 1985).  Similarly, cross-
linking DNAM-1 with mAb induces cytolysis mediated by CTL and NK cells and also 
results in tyrosine phosphorylation of the DNAM-1 molecule.  Presently, the tyrosine 
kinase responsible for DNAM-1 phosphorylation is unknown and further studies are 
warranted to define the biochemical events accompanying DNAM-1 signal transduction. 
 In summary, our studies have shown that DNAM-1 is a novel receptor involved in 
intercellular adhesion and lymphocyte signaling.  Adhesion molecules play a critical 
role in a variety of immune responses including allograft rejection, tolerance (Isobe, et 
al., 1992), cell differentiation (Gunji, et al., 1992), lymphocyte homing (Hogg & Landis, 
1993),  and viral and tumor immunity (Springer, 1990; Phillips, et al., 1991).  Since 
DNAM-1 is broadly expressed on a variety of peripheral leukocytes including T cells, NK 
cells, monocytes, and B cells, it may be involved in the wide range of immune 
responses. 
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Experimental Procedures 
 
Hybridomas and Cell Lines.  
 The anti-DNAM-1 mAb DX11 (IgG1, κ) was generated by fusing the Sp2/0 
myeloma cell line with splenocytes from a BALB/c mouse immunized with a human CTL 
clone.  Hybridomas were cloned by using a FACStar (Becton Dickinson 
Immunocytometry Systems, San Jose, CA).  Colo-205 is a colon carcinoma cell line, 
PA-1 is an ovarian teratocarcinoma cell line, SK-N-SH is a neuroblastoma cell line, 
MCF-7 is a breast carcinoma cell line, K562 is an erythroleukemia cell line, Jurkat is a T 
cell leukemia cell line, U937 is a myeloid leukemia cell line, JY and 721.221 are EBV-
transformed B lymphoblastoid cell lines (American Type Culture Collection, Rockville, 
MD).  BDMEL-1 is a melanoma cell line generated by our laboratory. Colo-205 and JY 
express HLA-A2. COS-7 cells were generously provided by Dr. Brian Seed, 
Massachusetts General Hospital, Boston, MA. 
 
mAbs and Flow Cytometry. 
 Control IgG, anti-CD3 (Leu 4 mAb), anti-CD18 (L130 mAb), anti-CD8α (Leu 2 
mAb), anti-CD56 (L185 mAb), anti-CD19 (Leu 12 mAb) and anti-CD14 (Leu M3 mAb) 
were generously provided by Becton Dickinson Immunocytometry Systems.  
CyChrome-conjugated anti-CD3 was purchased from Pharmingen, San Diego, CA.  
Anti-phosphotyrosine mAb (4G10) was purchased from Upstate Biotechnology Inc., 
Lake Placid, NY.  Anti-HLA-A2 mAb was purified from MA2.1 hybridoma obtained from 
ATCC (McMichael, A.J., et al, 1980).  F(ab')2 fragments were prepared by digesting 
DX11 mAb (IgG1) and anti-CD18 (IgG1) with immobilized pepsin (10 mg IgG in 10 ml of 
0.2 M sodium citrate, 0.15 M NaCl buffer, pH 3.5, with 2.5 ml immobilized pepsin for 2 h 
at 37oC) (Pierce, Rockford, IL), and afterwards removing residual intact mAb by protein 
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A affinity chromatography.  Purity of the F(ab')2 fragments were determined by SDS-
PAGE.  Methods of immunofluorescent staining and flow cytometry have been 
described previously (Lanier and Recktenwald, 1991).  Lymphocytes and monocytes 
were identified by their characteristic forward and right angle light scatter properties, as 
described previously  (Lanier and Recktenwald, 1991). 
 
CTL and NK clones. 
 CTL and NK clones were established from peripheral blood of healthy donors as 
described (Phillips, et al., 1991).  In brief, PBMC (Stanford Blood Center, Stanford, CA) 
were isolated by Ficoll/Hypaque centrifugation.  CD3+ T cell clones or CD3-CD56+ NK 
were cloned by flow cytometry and cultured using the conditions described previously 
(Yssel, et al., 1984).  Alloantigen (HLA-A2)-specific CTL clones were established from 
by mixed lymphocyte cultures using an HLA-A2+ EBV-transformed B lymphoblastoid 
cell line, JY, as the stimulator and PBMC from HLA-A2- donors as responders, as 
described (Yssel, et al., 1984; Phillips, et al., 1991).  
 
Cytotoxicity assay. 
 Cell lines were labeled with 51Cr and used as targets in a 4-h radioisotope 
release assay, as described (Lanier, et al., 1983).  Data are expressed as the means 
of triplicate cultures and the spontaneous radioisotope release was typically < 10% of 
total 51Cr release.  % cytolysis was calculated as: 
cpm specific 51Cr release - cpm spontaneous release  X 100 
cpm total 51Cr release - cpm spontaneous release 
 
Lymphokine assay. 
 1 x 105 CTL clones were incubated with 1 x 105 irradiated Colo-205 or JY cells in 
200 μl medium in U-bottomed 96-well plates (Becton Dickinson Labware, Lincoln Park, 
NJ) for 18 hr in the presence of the indicated mAbs (each at a final concentration of 10 
12 
μg/ml).  Supernatants were harvested and lymphokines were measured by ELISA, as 
described (Chretien, et al., 1989).  
 
Protein purification and sequencing. 
 2 x 1010 PBMC were lysed in 200 ml of lysis buffer (50 mM Tris, 150 mM NaCl, 
pH 8.0) containing 1% NP-40 and protease inhibitors (1 mM PMSF and 20 Kallikrein 
inhibitor U/ml aprotinin).  After removal of nuclei by centrifugation, the sample was 
incubated with 40 ml Con A Sepharose (Pharmacia, Uppsala, Sweden).  Glycoproteins 
were eluted with lysis buffer containing 0.5 M α-methyl-mannopyranoside and were 
passed through a column containing 10 ml of Sepharose CNBr-coupled (Sigma, St. 
Louis, MO) to a control murine IgG1 mAb.  DNAM-1 glycoproteins were then isolated 
by using a column containing 25 ml of Sepharose covalently coupled to the DX11 mAb 
(2 mg DX11 mAb/ml Sepharose beads) and were eluted with 50 ml of 50 mM 
diethylamine (pH >11.5).  The sample was concentrated to a final volume of 40 μl by 
using a Centricon-30 (Amicon Inc., Beverly, MA).  2X Laemmli  buffer was added and 
the proteins were separated by SDS-PAGE using 7% acrylamide gels (Bio-Rad, 
Richmond, CA) and blotted onto PVDF membranes (ProBlott, Applied Biosystems, 
Foster City, CA).  The membrane was stained with Coomassie blue (Bio-Rad) or 
Ponceau S (Sigma).  Membrane fragments containing the DNAM-1 protein were 
subjected to direct N-terminal sequencing at our institution or digested with trypsin for 
sequence determination of internal peptides at the Harvard Microsequencing Facility 
(Cambridge, MA).  Digested peptides were separated by reverse phase HPLC and 
sequencing was done with an Applied Biosystems 476A gas phase sequencer.  
 
cDNA cloning 
 Primary PCR was performed with a sense degenerative primer encoding the 
peptide EEVLWHT (an N-terminal  peptide fragment) and an antisense degenerative 
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primer encoding the peptide QQDSIA (an internal peptide fragment) using a human Th0 
T cell clone (MOT81) cDNA plasmid library as the template.  Using this primary PCR 
product as the  template, a second PCR was performed with a degenerative sense 
primer encoding the peptide PFAENM (another N-terminal peptide fragment) and the 
same antisense primer.  A 100-bp PCR product generated from the second PCR 
specifically hybridized with a 32P-radiolabeled oligonucleotide probe 5'-
TTTGCIGAIAACATGTCCCTIGAITGTGTITACCC-3' (I indicates inosine) encoding  the 
peptide FAENMSLECVYP in the N-terminal peptide fragment.  2 x 106 plasmid clones 
from the Th0 cDNA library were seeded into three 96-well plates and wells were 
screened by PCR for presence of the 100 bp DNAM-1 cDNA fragment.  Two positive 
wells were detected and the clones in these wells were screened by a standard colony 
hybridization method using the 32P-radiolabeled 100-bp fragment as a probe.  Two 
positive clones containing the same cDNA insert of 2.7 kb (plasmid LL378) were 
isolated and sequenced.  The DNAM-1 cDNA was subcloned into the pMET7 
expression vector and transfected into COS-7 cells using DEAE-dextran by the 
technique described previously (Aruffo and Seed, 1987).  Transfectants were stained 
by immunofluorescence and analyzed by flow cytometry. 
 
Biochemistry 
 Cells were labeled with 125I using lactoperoxidase and glucose oxidase and 
lysed in Tris-buffered saline (50 mM Tris, 15 mM NaCl, pH 8.0) containing 1% NP-40, 
protease inhibitors (1 mM PMSF and 20 Kallikrein inhibitor U/ml aprotinin) and 
phosphatase inhibitors (1 mM EGTA, 10 mM NaF, 1 mM Na4P2O7, 0.1 mM β-
glycerophosphate, 1 mM Na3VO4).  DNAM-1 glycoproteins were immunoprecipitated 
using the methods described previously (Lanier, et al., 1988) and treated with N-
glycosidase F (Boehringer Mannheim Corp., Indianapolis, IN) using the conditions 
recommended by the manufactures.  Samples were analyzed by SDS-PAGE. 
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 For the analysis of DNAM-1 phosphorylation, 5 x 105 HLA-A2-specific CTL were 
incubated with 1 x106 P815 cells and DX11 mAb in a total volume of 100 μl tissue 
culture medium (RPMI-1640 containing 10 % fetal calf serum) in U-bottomed 96-well 
plates.  At various times, the cell mixture was centrifuged, supernatants discarded, and 
the cells were solublized in 1% NP-40 Tris buffered saline pH 8.0 with phosphatase and 
protease inhibitors.  Lysates from 3 x 106 CTL were immunoprecipitated with the 
indicated mAbs, as described (Lanier, et al., 1988), and proteins were resolved by SDS-
PAGE.  Immunoprecipitates were transferred (100 V, 1 hr in 25 mM Tris, 192 mM 
glycine, 20% methanol) to PVDF membranes (Immobilon-P, Millipore)  Membranes 
were incubated overnight in Tris buffered saline containing 0.5% Tween 20 and MgCl2 
(TBST) and 10% non-fat dry milk and then incubated with FITC-conjugated DX11 mAb 
(1 μg/ml in TBST with 10% non-fat dried milk) for 2 hr at room temperature.  Proteins 
were detected by using HRP-conjugated sheep anti-FITC (Amersham, Arlington Heights, 
IL) and developed with SuperSignal CL-HRP Substrate (Pierce, Rockford, IL).  
Chemiluminescence was detected by autoradiograph.   
 
Cell adhesion assay 
 COS-7 cells were transfected with DNAM-1 or CD94 (Chang, et al., 1995) cDNA, 
as described (Aruffo and Seed, 1987).  51Cr-labeled Colo-205 cells were added to 24 
well plates containing adherent COS-7 cells expressing DNAM-1 or CD94 and 
incubated for 60 min at 370C in the presence or absence of DX11 mAb (10 μg/ml).  
After gently washing with tissue culture medium, cells were lysed in 10% Triton-X (in 
water) and radioactivity was measured.  Results are expressed as mean of triplicate 
cultures. 
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Figure Legends 
Figure 1.  A.  Anti-DNAM-1 mAb, DX11, and anti-CD18 (LFA-1β) mAb inhibit TcR-
independent cytolysis against a variety of tumor cell targets mediated by CTL clones.  
Colo-205, PA-1, SK-N-SH, BDMEL-1, MCF-7, and CaOV3 are non-hematopoietic tumor 
cells lines and do not express DNAM-1.  Hematopoietic cell lines tested include K562 
(DNAM-1 negative), Jurkat (DNAM-1 positive), U937 (DNAM-1 negative) and the 
721.221 and JY EBV-transformed B lymphoblastoid cell lines (both DNAM-1 positive).   
B.  DX11 mAb inhibits NK cell clone-mediated cytolysis against Colo-205, PA-1 and 
U937, but did not affect cytolysis of JY and 721.221.   Data are representative of 
experiments using several CTL and NK clones.  mAbs were used at 10 μg/ml and the 
effector to target ratio was 10 to 1. 
 
Figure 2.  Expression of DNAM-1 on peripheral blood mononuclear cells.  DNAM-1 is 
expressed on CD3+CD4+ T cells (90%), CD3+CD8+ T cells (80%), CD3+TcRγδ+ T 
cells (99%), CD3-CD56+ NK cells (97%), CD19+ B cells (3%), and monocytes (100%) 
in peripheral blood.  PBMC from a healthy donor were stained with phycoerythrin (PE)-
conjugated DX11, CyChrome-conjugated anti-CD3, and FITC-conjugated anti-CD4, 
anti-CD8α, anti-CD56, anti-CD19, or anti-CD14.  The cells were analyzed by flow 
cytometry using a FACScan.  An electronic gate was used to identify CD3+ (A) and 
CD3- (B) lymphocytes and monocytes (C) and the FITC (x-axis) and PE (y-axis) 
fluorescence of these populations were displayed as contour plots (4 decade log scales).  
>98% of PBMC stained with FITC-conjugated control murine IgG1 and PE-conjugated 
control murine IgG were present in the lower left quadrant of the contour plots (not 
shown).  Data are representative of results obtained using several different blood 
donors. 
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Figure 3.  A.  DNAM-1 expression on an HLA-A2-specific CD8+ CTL clone. Cells 
were stained with PE-conjugated DX11 mAb (shaded histogram) or PE-conjugated 
control IgG1 mAb (open histogram) and analyzed by flow cytometry.  B.  DX11 mAb 
inhibited cytolysis of Colo-205, but not JY, mediated by HLA-A2-specific CTL clones 
AS547.97, AS547.93, and AS547.91.  mAbs were used at 10 μg/ml and the effector to 
target ratio was 5 to 1.  C.  DX11 mAb inhibited the secretion of GM-CSF and TNF-α 
by an HLA-A2-specific CTL clones AS547.97 and AS 547.93 stimulated by Colo-205, 
but not JY.  mAbs were used at 10 μg/ml  
 
Figure 4.  A.  An HLA-A2-specific CD8+ CTL clone lysed murine FcR+ P815 cells in 
the presence of DX11 mAb or anti-CD3 mAb, but not DX11 F(ab')2 fragments.  Data 
are representative of experiments performed with several CTL clones.  mAbs were 
used at 10 μg/ml.  B.  HLA-A2-specific CTL were stimulated with DX11 mAb-
precoated P815 cells for indicated time.  Cells were then lysed and immunoprecipitated 
with control murine IgG1 mAb (cIg), DX11 mAb, or anti-phosphotyrosine mAb (4G10).  
The immunoprecipitates were analyzed by Western blot using DX11 mAb, showing that 
tyrosine residues of DNAM-1 are phosphorylated after the stimulation. 
 
Figure 5.  A.  Nucleotide and predicted amino acid sequences of DNAM-1.  The 
leader and putative transmembrane domain are underlined.  Peptide sequences that 
were obtained from purified DNAM-1 protein are indicated by dotted underlines.  
Potential N-linked glycosylation sites in the extracellular domain and tyrosine 
phosphorylation sites in the cytoplasmic region are circled and boxed, respectively.  
The GenBank accession number of DNAM-1 is U56102.  B.  Schematic diagram of 
DNAM-1 protein. Leader peptide, extracellular, transmembrane and cytoplasmic regions 
are indicated. Two pairs of cysteine residues in the extracellular portion potentially able 
to participate in intrachain disulfide-bonding for the formation of Ig-like domains are 
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indicated.  C.  DNAM-1 expression on COS-7 cells transfected with pMET7 vector 
alone (open histogram) or with DNAM-1 cDNA in pMET7 (shaded histogram).  D. 125I-
labeled COS-7 cells transfected with the DNAM-1 cDNA or PBMC were lysed and 
DNAM-1 antigen was immunoprecipitated with control murine IgG1 or DX11 mAb. The 
immunoprecipitates were  treated with N-glycosidase F, as indicated, and analyzed by 
SDS-PAGE.  
 
Figure 6.  51Cr-labeled Colo-205 cell bound adherent COS-7 cells transfected with 
DNAM-1 cDNA and the binding was specifically blocked by the DX11 mAb.  DX11 mAb 
was added to assay at 5 μg/ml.  51Cr-labeled Colo-205 cell did not bind to 
untransfected COS-7 cells (not shown). 
